| Product Code: ETC6738401 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Breakthrough Therapy Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Breakthrough Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 China Breakthrough Therapy Market - Industry Life Cycle |
3.4 China Breakthrough Therapy Market - Porter's Five Forces |
3.5 China Breakthrough Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Breakthrough Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in research and development for breakthrough therapies in China |
4.2.2 Rising prevalence of chronic diseases driving the demand for innovative treatment options |
4.2.3 Supportive government policies and regulations promoting the development and adoption of breakthrough therapies in China |
4.3 Market Restraints |
4.3.1 High costs associated with research, development, and commercialization of breakthrough therapies |
4.3.2 Stringent regulatory requirements for approval of breakthrough therapies in China |
4.3.3 Limited expertise and infrastructure for the manufacturing and distribution of advanced therapies in the Chinese market |
5 China Breakthrough Therapy Market Trends |
6 China Breakthrough Therapy Market, By Types |
6.1 China Breakthrough Therapy Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 China Breakthrough Therapy Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 China Breakthrough Therapy Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 China Breakthrough Therapy Market Revenues & Volume, By Infectious Disease, 2021- 2031F |
6.1.5 China Breakthrough Therapy Market Revenues & Volume, By Rare Disease, 2021- 2031F |
6.1.6 China Breakthrough Therapy Market Revenues & Volume, By Autoimmune Disease, 2021- 2031F |
6.1.7 China Breakthrough Therapy Market Revenues & Volume, By Pulmonary Disease, 2021- 2031F |
6.1.8 China Breakthrough Therapy Market Revenues & Volume, By Neurological Disorder, 2021- 2031F |
7 China Breakthrough Therapy Market Import-Export Trade Statistics |
7.1 China Breakthrough Therapy Market Export to Major Countries |
7.2 China Breakthrough Therapy Market Imports from Major Countries |
8 China Breakthrough Therapy Market Key Performance Indicators |
8.1 Number of patents filed for breakthrough therapies in China |
8.2 Investment trends in the biopharmaceutical sector in China |
8.3 Number of clinical trials conducted for breakthrough therapies in China |
9 China Breakthrough Therapy Market - Opportunity Assessment |
9.1 China Breakthrough Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Breakthrough Therapy Market - Competitive Landscape |
10.1 China Breakthrough Therapy Market Revenue Share, By Companies, 2024 |
10.2 China Breakthrough Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here